Ann Arbor’s Xoran Technologies Patents Stroke Detection Device

28
Ann Arbor's Xoran Technologies has received a patent on a device that could make possible fast, accurate stroke diagnosis on the go. // Stock Photo
Ann Arbor’s Xoran Technologies has received a patent on a device that could make possible fast, accurate stroke diagnosis on the go. // Stock Photo

Xoran Technologies in Ann Arbor, developer of low-dose radiation cone beam computed tomography (CT) systems, has received a patent for a modular CT system assembly.

“This revolutionary cone beam CT configuration paired with our 20-and-counting current patents unlocks new capabilities. The technology is just the beginning of a new generation of Xoran’s point-of-care (POC) imaging devices,” says Misha Rakic, CEO of Xoran.

“In the future, this advancement means that ultra-compact CT can fit into existing ambulances for early stroke detection without the need for a dedicated mobile stroke unit. It can be used by first responders in front-line and natural disaster scenarios as well as by military on the battlefield. The possibilities for highly deployable head CT are virtually limitless.”

The patented and prototyped highly compact cranial CT device could in the future enable cerebral perfusion studies to be performed in a wider range of clinical settings, to service more patients — rapidly and at the point of care after the onset of stroke symptoms.

According to the Centers for Disease Control and Protection (CDC), more than 795,000 individuals suffer from strokes each year in the U.S. When an individual is suffering from acute stroke, time is of the essence.

Tt is critically important, the company says, to assess the type of stroke as well as the amount and location of potentially recoverable brain tissue to determine the appropriate treatment routing and priority to achieve the best outcome for that individual.

For more information visit xorantech.com.

Facebook Comments